drugset / Trial / NCT00002475

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

NCT00002475

Phase 2 Completed 40 enrolled St. Vincent Medical Center - Los Angeles
Treatment

Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Vaccines made from a patient's tumor tissue may make the body build an immune response to kill tumor cells. Chemotherapy combined with vaccine therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining cyclophosphamide with tumor cell vaccine in treating patients who have metastatic cancer or cancer at high risk of recurrence.

Timeline

Start
1991-04
Primary completion
2007-12
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Intravenous
Subject allogeneic tumor cell vaccine Vaccine Intramuscular
Subject autologous tumor cell vaccine Vaccine Intramuscular
Background Interferon gamma-1b Protein / enzyme biologic
Background interferon alfa-2b Protein / enzyme biologic
Background sargramostim Protein / enzyme biologic Subcutaneous